Technical Analysis for AIFF - Firefly Neuroscience, Inc.

Grade Last Price % Change Price Change
F 3.01 -2.59% -0.08
AIFF closed down 2.59 percent on Friday, November 1, 2024, on 26 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
20 DMA Resistance Bearish -2.59%
Outside Day Range Expansion -2.59%
Wide Bands Range Expansion -2.59%
Oversold Stochastic Weakness -2.59%

   Recent Intraday Alerts

Alert Time
Down 3% about 22 hours ago
Fell Below Previous Day's Low about 22 hours ago
60 Minute Opening Range Breakdown 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Firefly Neuroscience, Inc. Description

Firefly is an Artificial Intelligence (“AI”) technology company dedicated to developing groundbreaking neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA) platform revolutionizes diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has invested approximately $60 million in developing its BNA platform, building a comprehensive database of brain wave tests, securing patent protection, and achieving FDA approval. The Company is now launching the BNA platform commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.


Classification

Sector: Technology
Industry: Information Technology Services
Keywords: Pharmaceutical Artificial Intelligence FDA Neurological Disorders Dementia Depression Major Depressive Disorder Neurology Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Mental Disorder Learning Disabilities Psychopathology

Is AIFF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.9
52 Week Low 2.74
Average Volume 241,753
200-Day Moving Average 6.16
50-Day Moving Average 3.60
20-Day Moving Average 3.38
10-Day Moving Average 3.46
Average True Range 0.58
RSI (14) 43.18
ADX 33.51
+DI 29.77
-DI 15.98
Chandelier Exit (Long, 3 ATRs) 4.09
Chandelier Exit (Short, 3 ATRs) 4.47
Upper Bollinger Bands 4.13
Lower Bollinger Band 2.62
Percent B (%b) 0.26
BandWidth 44.83
MACD Line -0.12
MACD Signal Line -0.11
MACD Histogram -0.0109
Fundamentals Value
Market Cap 6.06 Million
Num Shares 2.01 Million
EPS -7.31
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 0.49
Price-to-Book 1.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.42
Resistance 3 (R3) 3.44 3.33 3.35
Resistance 2 (R2) 3.33 3.23 3.32 3.32
Resistance 1 (R1) 3.17 3.16 3.12 3.15 3.30
Pivot Point 3.06 3.06 3.03 3.05 3.06
Support 1 (S1) 2.90 2.96 2.85 2.88 2.72
Support 2 (S2) 2.79 2.89 2.78 2.70
Support 3 (S3) 2.63 2.79 2.67
Support 4 (S4) 2.61